6 Results for "

BCL6-BTB

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "BCL6-BTB" in MCE Product Catalog:

  • Categories Recommended:
    More
Cat. No.: HY-161138
Target:  

BCL6 Apoptosis

Research Areas:  

Cancer

WK369 is a novel BCL6 small molecule inhibitor, which exhibits excellent anti-ovarian cancer bioactivity, induces cell cycle arrest and causes apoptosis. WK369 can directly bind to the BCL6-BTB domain and block the interaction between BCL6 and SMRT, leading to the reactivation of p53, ATR and CDKN1A .
loading...
    loading...
Cat. No.: HY-177755
CAS No.: 2230406-52-5
Target:  

Molecular Glues BCL6

Research Areas:  

Cancer

BCL6-IN-10 is a molecular glue inhibitor targeting the BCL6 BTB domain with an IC50 of 4 nM. BCL6-IN-10 blocks the interaction between BCL6 and transcriptional co-repressors, and induces partial degradation of BCL6 via the ubiquitin-proteasome pathway, thereby de-repressing BCL6 target genes and inhibiting cancer cell proliferation. BCL6-IN-10 can be used in the research of diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-177756
CAS No.: 2230406-60-5
Target:  

BCL6

Research Areas:  

Cancer

BCL6-IN-11 is a potent inhibitor of the BCL6 BTB domain and a partial degrader of BCL6. BCL6-IN-11 inhibits the interaction between the BCL6 BTB domain and BCOR with an IC50 of 6 nM. BCL6-IN-11 can be used for research related to BCL6 degradation in diffuse large B-cell lymphoma (DLBCL) .
loading...
    loading...
Cat. No.: HY-169218
CAS No.: 2694055-38-2
Target:  

BCL6

Research Areas:  

Cancer

WK692 is a BCL6 inhibitor that inhibits the BCL6 BTB/SMRT interaction. WK692 can effectively inhibit the growth of diffuse large B-cell lymphoma cells and synergize with EZH2 and PRMT5 inhibitors. .
loading...
    loading...
Cat. No.: HY-P10543
CAS No.: 857026-08-5
Target:  

BCL6

Research Areas:  

Cancer

SMRT peptide is one of the co-repressors of BCL6 BTB domain interaction. SMRT peptide binds to the BTB domain of BCL6 and enhances the transcriptional repression function of BCL6. SMRT peptide can be used to study protein-protein interactions .
loading...
    loading...
Cat. No.: HY-208744
CAS No.: 2374712-76-0
Target:  

BCL6

Research Areas:  

Cancer

BCL6-IN-14 is a BCL6 inhibitor with a Kd value of 41.1 μM for the BCL6 BTB domain. BCL6-IN-14 inhibits Karpas-422 tumors. BCL6-IN-14 can be used in cancer-related research .
loading...
    loading...